Stingray8
05-22
$UnitedHealth(UNH)$  UnitedHealth Group (UNH) stock has taken a hit after HSBC downgraded it to "reduce" with a target price of $270, down from $490. Additionally, Wolfe Research cut its price target to $390 with an "outperform" rating. The stock's current price is around $302.98, and it's down 5.78% with a previous close of $321.58. Ultimately, whether it's time to buy UNH stock at $295 depends on your individual investment goals, risk tolerance, and analysis of the company's fundamentals. Can consider dollar-cost averaging if the price drops further, and hold on for the next bull run. Dyodd. 
UNH Leads the Charge: Is Defense the New Offense?
UnitedHealth shares gained 4.5% and led Dows rally on Tuesday. As the broader market continues to hit new highs, upward momentum is slowing, and sector rotation has begun. Most of the Magnificent 7 pulled back yesterday, while investors shifted toward defensive sectors like healthcare. Have you allocated any positions to defensive stocks? Which defensive stock or ETF do you have the most confidence in? UNH is still down 35% year-to-date — has this year been a continuous buying opportunity for UNH?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment
2